Skip to main content

Table 3 Characteristics of patients with persistent disease according to the 2015 ATA risk-stratification system

From: Tumor burden of persistent disease in patients with differentiated thyroid cancer: correlation with postoperative risk-stratification and impact on outcome

 

LR

(n = 22)

IR

(n = 66)

HR

(n = 19)

p

PD tumor burden

 Very small-volume

13 (59%)

11 (17%)

0

 

 Small-volume

5 (23%)

18 (27%)

2 (11%)

<.0001

 Large-volume

4 (18%)

37 (56%)

17 (89%)